SAXAGLIPTIN Side Effects

7022991-5 | Polymyalgia Rheumatica
on Sep 22, 2010 Female patient from JAPAN , 66 years of age, weighting 108.0 lb, was diagnosed with type 2 diabetes mellitus, pain (What is pain?) and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: polymyalgia rheumatica (What is polymyalgia rheumatica?). Saxagliptin dosage: . During the same period patient was treated with MUCOSTA (Tablet) (View Mucosta Review and Mucosta Label ), LOXONIN (Tablet) (View Loxonin Review and Loxonin Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), CRESTOR (Tablet) (View Crestor Review and Crestor Label ), ARTIFICIAL TEARS (Mytear Boric Acid-inorganic, Eye Drops) (View Artificial Tears Review and Artificial Tears Label ). Patient was hospitalized.

7009263-X | Arthritis, Psoriasis, Rash
Patient was taking Saxagliptin (View Usage). Patient had the following side effects: arthritis (What is arthritis?), psoriasis, rash (What is rash?) on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 74 years of age, was diagnosed with diabetes mellitus and. Saxagliptin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), METFORMIN (View Metformin Review and Metformin Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ).

6973064-9 | Prostate Cancer, Viith Nerve Paralysis
Adverse event was reported on Aug 31, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: 07jun10) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 62 years of age, weighting 163.1 lb, After Saxagliptin was administered, patient had the following side effects: prostate cancer (What is prostate cancer?), viith nerve paralysis. During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tape(including Poultice)) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6958021-0 | Hepatic Neoplasm Malignant
on Aug 18, 2010 Male patient from AUSTRIA , 66 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, hyperuricaemia, thrombosis prophylaxis and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant. Saxagliptin dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACECOMB (View Acecomb Review and Acecomb Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (Tablet) (View Aspirin Review and Aspirin Label ).


6941104-9 | Myalgia
on Aug 19, 2010 Female patient from UNITED KINGDOM , 59 years of age, weighting 220.5 lb, was diagnosed with diabetes mellitus and was treated with Saxagliptin (View Usage). Patient had the following side effects: myalgia. Saxagliptin dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DIAMICRON (Diamicron Mr) (View Diamicron Review and Diamicron Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6931970-5 | Diabetes Mellitus Inadequate Control, Diabetic Neuropathy, Prostatic Specific Antigen Increased, Viith Nerve Paralysis
Patient was taking Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: diabetes mellitus inadequate control, diabetic neuropathy, prostatic specific antigen increased, viith nerve paralysis on Aug 11, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: . During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tape(including Poultice)) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6923306-0 | Chest Pain
Adverse event was reported on Aug 05, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: Formulation:tablet;interrupted 15jul2010(160d).restart On 16jul2010 + Stopped On 03aug2010(19d)) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 46 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). During the same period patient was treated with NABOAL (1% Gel) (View Naboal Review and Naboal Label ), EPALRESTAT (Tablet) (View Epalrestat Review and Epalrestat Label ), KETOPROFEN (Mohrus Tape) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6922709-8 | Viith Nerve Paralysis
on Aug 04, 2010 Male patient from JAPAN , 62 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient had the following side effects: viith nerve paralysis. Saxagliptin dosage: . During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tape(including Poultice)) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6922626-3 | Polymyalgia Rheumatica
on Aug 05, 2010 Female patient from JAPAN , 66 years of age, weighting 108.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: polymyalgia rheumatica (What is polymyalgia rheumatica?). Saxagliptin dosage: . During the same period patient was treated with MUCOSTA (Tablet) (View Mucosta Review and Mucosta Label ), LOXONIN (Tablet) (View Loxonin Review and Loxonin Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), CRESTOR (Tablet) (View Crestor Review and Crestor Label ), ARTIFICIAL TEARS (Mytear Boric Acid-inorganic, Eye Drops) (View Artificial Tears Review and Artificial Tears Label ). Patient was hospitalized.

6918829-4 | Chest Pain, Diabetic Neuropathy
Patient was taking Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), diabetic neuropathy on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , 46 years of age, weighting 130.1 lb, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: Formulation:tablet;interrupted 15jul2010(160d).restart On 16jul2010 + Stopped On 03aug2010(19d). During the same period patient was treated with NABOAL (1% Gel) (View Naboal Review and Naboal Label ), EPALRESTAT (Tablet) (View Epalrestat Review and Epalrestat Label ). Patient was hospitalized.

6918826-9 | Viith Nerve Paralysis
Adverse event was reported on Jul 30, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 62 years of age, weighting 163.1 lb, Patient had the following side effects: viith nerve paralysis. During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tabs) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6905592-6 | Pancreatitis Acute
on Jul 27, 2010 Male patient from ARGENTINA , 60 years of age, was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: pancreatitis acute. Saxagliptin dosage: .

6899317-0 | Back Pain
on Jul 24, 2010 Female patient from JAPAN , 66 years of age, weighting 108.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?). Saxagliptin dosage: . During the same period patient was treated with MUCOSTA (Tablet) (View Mucosta Review and Mucosta Label ), LOXONIN (Tablet) (View Loxonin Review and Loxonin Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), CRESTOR (Tablet) (View Crestor Review and Crestor Label ), ARTIFICIAL TEARS (Mytear Boric Acid-inorganic, Eye Drops) (View Artificial Tears Review and Artificial Tears Label ). Patient was hospitalized.

6899308-X | Chest Pain
Patient was taking Saxagliptin (View Usage). Patient had the following side effects: chest pain (What is chest pain?) on Jul 21, 2010 from JAPAN Additional patient health information: Male patient , 46 years of age, weighting 130.1 lb, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: Formulation:tablet;interrupted 15jul2010(159d).restart On 16jul2010.. During the same period patient was treated with NABOAL (1% Gel) (View Naboal Review and Naboal Label ), EPALRESTAT (Tablet) (View Epalrestat Review and Epalrestat Label ). Patient was hospitalized.

6883906-3 | Chest Pain
Adverse event was reported on Jul 17, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: Formulation:tablet;taken Till 13jul10(159d)) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 46 years of age, After Saxagliptin was administered, patient had the following side effects: chest pain (What is chest pain?). During the same period patient was treated with NABOAL (1% Gel) (View Naboal Review and Naboal Label ). Patient was hospitalized.

6879344-X | Viith Nerve Paralysis
on Jul 16, 2010 Male patient from JAPAN , 62 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: viith nerve paralysis. Saxagliptin dosage: . During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tabs) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6879343-8 | Back Pain
on Jul 15, 2010 Female patient from JAPAN , 66 years of age, weighting 108.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient had the following side effects: back pain (What is back pain?). Saxagliptin dosage: . During the same period patient was treated with MUCOSTA (Tablet) (View Mucosta Review and Mucosta Label ), LOXONIN (Tablet) (View Loxonin Review and Loxonin Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), CRESTOR (Tablet) (View Crestor Review and Crestor Label ), ARTIFICIAL TEARS (Mytear Boric Acid-inorganic, Eye Drops) (View Artificial Tears Review and Artificial Tears Label ). Patient was hospitalized.

6876484-6 | Viith Nerve Paralysis
Patient was taking Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: viith nerve paralysis on Jul 12, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: . During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tabs) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6871950-1 | Renal Impairment
Adverse event was reported on Jun 09, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: SOUTH AFRICA , 45 years of age, weighting 216.1 lb, Patient experienced the following unwanted or unexpected effects: renal impairment. During the same period patient was treated with ACTRAPHANE (1df-32 Unit Nos; 32 Units In Morning, 28 Units In The Night.) (View Actraphane Review and Actraphane Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ADALAT (View Adalat Review and Adalat Label ), COVERSYL (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), RIDAQ (View Ridaq Review and Ridaq Label ).

6839025-5 | Viith Nerve Paralysis
on Jul 05, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient had the following side effects: viith nerve paralysis. Saxagliptin dosage: . During the same period patient was treated with MAGLAX (Tabs) (View Maglax Review and Maglax Label ), ARTIST (Tabs) (View Artist Review and Artist Label ), ASPIRIN (Tabs) (View Aspirin Review and Aspirin Label ), REBAMIPIDE (Tabs) (View Rebamipide Review and Rebamipide Label ), KETOPROFEN (Tabs) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

6816926-5 | Coronary Artery Disease, Myocardial Infarction, Reflux Oesophagitis
on Jun 30, 2010 Female patient from UNITED KINGDOM , 74 years of age, weighting 156.5 lb, was diagnosed with diabetes mellitus and was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?), myocardial infarction, reflux oesophagitis. Saxagliptin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6791179-5 | Renal Impairment, Rhabdomyolysis
Patient was taking Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: renal impairment, rhabdomyolysis on Jun 09, 2010 from SOUTH AFRICA Additional patient health information: Male patient , 45 years of age, weighting 216.1 lb, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: . During the same period patient was treated with ACTRAPHANE (1df-32 Unit Nos; 32 Units In Morning, 28 Units In The Night.) (View Actraphane Review and Actraphane Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ADALAT (View Adalat Review and Adalat Label ), COVERSYL (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), RIDAQ (View Ridaq Review and Ridaq Label ).

6780444-3 | Cardiac Failure
Adverse event was reported on Jun 16, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED KINGDOM , 81 years of age, Patient had the following side effects: cardiac failure. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), CO AMILOFRUSE (View Co-amilofruse Review and Co-amilofruse Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), MOMETASONE FUROATE (View Mometasone Furoate Review and Mometasone Furoate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), QUININE SULFATE (View Quinine Sulfate Review and Quinine Sulfate Label ).

6780442-X | Renal Impairment, Rhabdomyolysis
on Jun 09, 2010 Male patient from SOUTH AFRICA , 45 years of age, weighting 216.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: renal impairment, rhabdomyolysis. Saxagliptin dosage: . During the same period patient was treated with ACTRAPHANE (1df-32 Unit Nos; 32 Units In Morning, 28 Units In The Night.) (View Actraphane Review and Actraphane Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ADALAT (View Adalat Review and Adalat Label ), COVERSYL (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), RIDAQ (View Ridaq Review and Ridaq Label ).

6763327-4 | Rash
on Jun 08, 2010 Male patient from UNITED STATES , 73 years of age, weighting 241.0 lb, was diagnosed with diabetes mellitus and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Saxagliptin dosage: .

6737035-X | Reflux Oesophagitis
Patient was taking Saxagliptin (View Usage). Patient had the following side effects: reflux oesophagitis on May 11, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 74 years of age, weighting 156.5 lb, was diagnosed with diabetes mellitus and. Saxagliptin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6717952-7 | Myalgia
Adverse event was reported on May 05, 2010 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 70 years of age, weighting 180.8 lb, After Saxagliptin was administered, patient had the following side effects: myalgia.

6619328-X | Rhabdomyolysis, Sepsis, Urinary Tract Infection
on Mar 01, 2010 Male patient from GERMANY , 56 years of age, weighting 205.0 lb, was diagnosed with type 2 diabetes mellitus, benign prostatic hyperplasia and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Saxagliptin dosage: 1df=1 Tablet;02may-21jul09(11wks 4 Days) 1mg,2.5mg,5mg For 12 Weeks. During the same period patient was treated with CIPROFLOXACIN (Iv Drip: 300mg/d; 03aug09-04aug09;less Than 1month) (View Ciprofloxacin Review and Ciprofloxacin Label ), DIOVAN (29aug07-aug09;aug09-ong;dur:2 Yrs) (View Diovan Review and Diovan Label ), NORVASC (29aug07-aug09;aug09-ong;dur:2 Yrs) (View Norvasc Review and Norvasc Label ), HARNAL (View Harnal Review and Harnal Label ), MEROPENEM (Inj Form) (View Meropenem Review and Meropenem Label ). Patient was hospitalized.

5628041-7 |
on Feb 08, 2008 Male patient from SINGAPORE , 56 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). . Saxagliptin dosage: Bottle1:31-5-07/08-2-08 Po; Bottle 2:31-5-07/08-2-08 Po; Bottle 3:06-6-07/08-2-08 Po.. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5625323-X |
Patient was taking Saxagliptin (View Usage). on Feb 08, 2008 from SINGAPORE Additional patient health information: Male patient , 56 years of age, was diagnosed with type 2 diabetes mellitus and. Saxagliptin dosage: Bottle1:31-5-07/08-2-08 Po; Bottle 2:31-5-07/08-2-08 Po; Bottle 3:06-6-07/08-2-08 Po.. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5546313-1 | Pneumococcal Sepsis
Adverse event was reported on Dec 05, 2007 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: pneumococcal sepsis. During the same period patient was treated with BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), CADUET (View Caduet Review and Caduet Label ).

5522573-8 | Sepsis
on Nov 16, 2007 Male patient from UNITED STATES , 47 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). Patient had the following side effects: sepsis (What is sepsis?). Saxagliptin dosage: . During the same period patient was treated with BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), CADUET (View Caduet Review and Caduet Label ).

5481682-2 | Gastritis Erosive, Pancreatitis Acute
on Oct 05, 2007 Female patient from GERMANY , 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: gastritis erosive, pancreatitis acute. Saxagliptin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (Enalapril-hypothiazide 20/12.5mg) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VINPOCETINE (View Vinpocetine Review and Vinpocetine Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DROTAVERINE (View Drotaverine Review and Drotaverine Label ). Patient was hospitalized.

5348003-7 | Toxic Skin Eruption
Patient was taking Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic skin eruption on May 25, 2007 from GERMANY Additional patient health information: Male patient , 54 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and. Saxagliptin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), INDAPAMID (View Indapamid Review and Indapamid Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5328772-2 | Toxic Skin Eruption
Adverse event was reported on May 08, 2007 by a Male patient taking Saxagliptin (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: GERMANY , 54 years of age, Patient had the following side effects: toxic skin eruption. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INDAPAMID (View Indapamid Review and Indapamid Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5314709-9 | Gastritis Erosive, Pancreatitis Acute
on Apr 20, 2007 Female patient from GERMANY , 63 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Saxagliptin (View Usage). After Saxagliptin was administered, patient had the following side effects: gastritis erosive, pancreatitis acute. Saxagliptin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (Enalapril-hypothiazide 20/12.5mg) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VINPOCETINE (View Vinpocetine Review and Vinpocetine Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DROTAVERINE (View Drotaverine Review and Drotaverine Label ). Patient was hospitalized.

5299495-3 | Pancreatitis Acute
on Apr 05, 2007 Female patient from GERMANY , 63 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Saxagliptin (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Saxagliptin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (Enalapril-hypothiazide 20/12.5mg) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VINPOCETINE (View Vinpocetine Review and Vinpocetine Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5199991-3 | Hypertensive Emergency
Patient was taking Saxagliptin (View Usage). Patient had the following side effects: hypertensive emergency on Dec 24, 2006 from SINGAPORE Additional patient health information: Male patient , 49 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and. Saxagliptin dosage: . During the same period patient was treated with PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.